Liver X receptor regulation of thyrotropin-releasing hormone transcription in mouse hypothalamus is dependent on thyroid status

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Ghaddab Zroud, Rym ^a   Seugnet, Isabelle ^a   Steffensen, Knut R ^b   Demeneix, Barbara A ^a   Clerget Froidevaux, Marie Stéphanie ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER G1; ACYL COENZYME A DESATURASE; BINDING PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIOTHYRONINE; LIPOPROTEIN LIPASE; LIVER X RECEPTOR; MELANOCORTIN 4 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTIRELIN; RETINOID X RECEPTOR; RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THYROID HORMONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ORPHAN NUCLEAR RECEPTOR; PROTEIN BINDING;

ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIMERIZATION; EUTHYROIDISM; FETUS; GENE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSCRIPTION; HETERODIMERIZATION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IN VIVO STUDY; INFLAMMATION; MC4R GENE; METABOLIC REGULATION; METABOLISM; MOLECULAR INTERACTION; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRH GENE; ANIMAL; FEMALE; GENETICS; PREGNANCY; THYROID GLAND;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; FEMALE; HYPOTHALAMUS; MICE; ORPHAN NUCLEAR RECEPTORS; PREGNANCY; PROTEIN BINDING; THYROID GLAND; THYROTROPIN-RELEASING HORMONE;

EID: 84907188886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106983     Document Type: Article

References (60)

1. Montague CT, O'Rahilly S (2000) The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49: 883-888.
2. Matsuzawa Y, Funahashi T, Nakamura T (1999) Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892: 146-154.
3. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
4. Grundy SM (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595-2600.
5. Jakobsson T, Treuter E, Gustafsson JA, Steffensen KR (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 33: 394-404.
6. Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, et al. (2002) Patterns of liver gene expression governed by TRbeta. Mol Endocrinol 16: 1257-1268.
7. Francis GA, Fayard E, Picard F, Auwerx J (2003) Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
8. Liu YY, Brent GA (2010) Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab 21: 166-173.
9. Kawai K, Sasaki S, Morita H, Ito T, Suzuki S, et al. (2004) Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation. Endocrinology 145: 5515-5524.
10. Shulman AI, Mangelsdorf DJ (2005) Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353: 604-615.
11. Lechan RM, Fekete C (2006) The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 153: 209-235.
12. Decherf S, Seugnet I, Kouidhi S, Lopez-Juarez A, Clerget-Froidevaux M-S, et al. (2010) Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proceedings of the National Academy of Sciences of the United States of America 107: 4471-4476.
13. Kouidhi S, Seugnet I, Decherf S, Guissouma H, Elgaaied AB, et al. (2010) Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo. Mol Cell Endocrinol 317: 44-52.
14. Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, et al. (2010) Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 13: 877-882.
15. Balkan W, Tavianini MA, Gkonos PJ, Roos BA (1998) Expression of rat thyrotropin-releasing hormone (TRH) gene in TRH-producing tissues of transgenic mice requires sequences located in exon 1. Endocrinology 139: 252-259.
16. Chen Y, Duan Y, Kang Y, Yang X, Jiang M, et al. (2012) Activation of liver X receptor induces macrophage interleukin-5 expression. J Biol Chem 287: 43340-43350.
17. Guissouma H, Ghorbel MT, Seugnet I, Ouatas T, Demeneix BA (1998) Physiological regulation of hypothalamic TRH transcription in vivo is T3 receptor isoform specific. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 12: 1755-1764.
18. Decherf S, Seugnet I, Becker N, Demeneix BA, Clerget-Froidevaux MS (2013) Retinoic X receptor subtypes exert differential effects on the regulation of Trh transcription. Mol Cell Endocrinol 381: 115-123.
19. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE (2008) Mice lacking the thyroid hormone receptor-alpha gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. Endocrinology 149: 6471-6486.
20. Zhao C, Dahlman-Wright K (2010) Liver X receptor in cholesterol metabolism. J Endocrinol 204: 233-240.
21. Pramfalk C, Pedrelli M, Parini P (2011) Role of thyroid receptor beta in lipid metabolism. Biochim Biophys Acta 1812: 929-937.
22. Korach-Andre M, Archer A, Barros RP, Parini P, Gustafsson JA (2011) Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity. Proc Natl Acad Sci U S A 108: 403-408.
23. Ishida E, Hashimoto K, Okada S, Satoh T, Yamada M, et al. (2013) Crosstalk between thyroid hormone receptor and liver X receptor in the regulation of selective Alzheimer's disease indicator-1 gene expression. PloS one 8: e54901.
24. Gofflot F, Chartoire N, Vasseur L, Heikkinen S, Dembele D, et al. (2007) Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell 131: 405-418.
25. Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, et al. (2006) 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem 281: 12799-12808.
26. Christoffolete MA, Doleschall M, Egri P, Liposits Z, Zavacki AM, et al. (2010) Regulation of thyroid hormone activation via the liver X-receptor/retinoid Xreceptor pathway. J Endocrinol 205: 179-186.
27. Koller KJ, Wolff RS, Warden MK, Zoeller RT (1987) Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci U S A 84: 7329-7333.
28. Clerget-Froidevaux MS, Seugnet I, Demeneix BA (2004) Thyroid status coregulates thyroid hormone receptor and co-modulator genes specifically in the hypothalamus. FEBS letters 569: 341-345.
29. Shibusawa N, Hollenberg AN, Wondisford FE (2003) Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem 278: 732-738.
30. Froidevaux MS, Berg P, Seugnet I, Decherf S, Becker N, et al. (2006) The cochaperone XAP2 is required for activation of hypothalamic thyrotropinreleasing hormone transcription in vivo. EMBO Rep 7: 1035-1039.
31. Hollenberg AN, Monden T, Flynn TR, Boers ME, Cohen O, et al. (1995) The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9: 540-550.
32. Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116: 607-614.
33. Baldan A, Bojanic DD, Edwards PA (2009) The ABCs of sterol transport. J Lipid Res 50 Suppl: S80-85.
34. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93: 693-704.
35. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
36. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, et al. (2002) Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277: 11019-11025.
37. Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ (2001) Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 276: 43018-43024.
38. Hashimoto K, Ishida E, Matsumoto S, Okada S, Yamada M, et al. (2009) Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology 150: 3417-3424.
39. Hashimoto K, Matsumoto S, Yamada M, Satoh T, Mori M (2007) Liver X receptor-alpha gene expression is positively regulated by thyroid hormone. Endocrinology 148: 4667-4675.
40. Hashimoto K, Yamada M, Matsumoto S, Monden T, Satoh T, et al. (2006) Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology 147: 4292-4302.
41. Paton CM, Ntambi JM (2009) Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 297: E28-37.
42. Flowers MT, Ntambi JM (2009) Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim Biophys Acta 1791: 85-91.
43. Dobrzyn P, Jazurek M, Dobrzyn A (2010) Stearoyl-CoA desaturase and insulin signaling-what is the molecular switch? Biochim Biophys Acta 1797: 1189-1194.
44. Thaler JP, Choi SJ, Schwartz MW, Wisse BE (2010) Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol 31: 79-84.
45. Cintra DE, Ropelle ER, Moraes JC, Pauli JR, Morari J, et al. (2012) Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PloS one 7: e30571.
46. Lopez M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez CR, et al. (2010) Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16: 1001-1008.
47. Guo F, Bakal K, Minokoshi Y, Hollenberg AN (2004) Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology 145: 2221-2227.
48. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, et al. (2000) alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 20: 1550-1558.
49. Goldberg IJ, Soprano DR, Wyatt ML, Vanni TM, Kirchgessner TG, et al. (1989) Localization of lipoprotein lipase mRNA in selected rat tissues. J Lipid Res 30: 1569-1577.
50. Wang H, Eckel RH (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297: E271-288.
51. Wang M, Miller RA (2012) Augmented autophagy pathways and MTOR modulation in fibroblasts from long-lived mutant mice. Autophagy 8: 1273-1274.
52. Sodhi RK, Singh N (2013) Liver X receptors: emerging therapeutic targets for Alzheimer's disease. Pharmacol Res 72: 45-51.
53. Zhang F, Kang Z, Li W, Xiao Z, Zhou X (2012) Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer's disease. J Clin Neurosci 19: 946-949.
54. Crupi R, Paterniti I, Campolo M, Di Paola R, Cuzzocrea S, et al. (2013) Exogenous T3 administration provides neuroprotection in a murine model of traumatic brain injury. Pharmacol Res 70: 80-89.
55. Zandbergen F, Plutzky J (2007) PPARalpha in atherosclerosis and inflammation. Biochim Biophys Acta 1771: 972-982.
56. Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, et al. (2006) A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor. Circ Res 99: e88-99.
57. Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, et al. (2003) Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 120: 246-255.
58. Fernandez V, Videla LA, Tapia G, Israel Y (2002) Increases in tumor necrosis factor-alpha in response to thyroid hormone-induced liver oxidative stress in the rat. Free Radic Res 36: 719-725.
59. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD (2005) Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 81: 403-411.
60. Alkemade A, Visser TJ, Fliers E (2008) Thyroid hormone signaling in the hypothalamus. Curr Opin Endocrinol Diabetes Obes 15: 453-458.